Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Seong Kyun Na, Byung-Cheol Song

Clin Mol Hepatol. 2019;25(3):234-244. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0108

View: 8027 Download: 245 Web of Science: 21 Crossref: 23

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 5794 Download: 179 Web of Science: 4 Crossref: 5

Original Article

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection

Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji

Clin Mol Hepatol. 2019;25(1):65-73. Published online February 25, 2019

DOI: https://doi.org/10.3350/cmh.2018.0070

View: 8314 Download: 133 Web of Science: 5 Crossref: 4

Review

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals

Soon Young Ko, Won Hyeok Choe

Clin Mol Hepatol. 2018;24(4):351-357. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0063

View: 9687 Download: 349 Web of Science: 4 Crossref: 1

Editorial

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):294-296. Published online September 11, 2018

DOI: https://doi.org/10.3350/cmh.2018.1009

View: 6471 Download: 79 Web of Science: 2 Crossref: 2

Review

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 14246 Download: 219 Web of Science: 18 Crossref: 27

Editorial

Use of sofosbuvir in chronic kidney disease: Is it necessary?

Tae Seop Lim, Sang Hoon Ahn

Clin Mol Hepatol. 2017;23(4):308-310. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2017.0109

View: 5776 Download: 118 Web of Science: 4 Crossref: 6

Original Article

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.358

View: 8242 Download: 102 Web of Science: 12 Crossref: 11

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim

Clin Mol Hepatol. 2015;21(2):125-130. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.125

View: 9115 Download: 64 Web of Science: 4 Crossref: 4

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.177

View: 6859 Download: 57 Web of Science: 4 Crossref: 4

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.38

View: 8500 Download: 81 Web of Science: 32 Crossref: 31

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C

Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2012;18(4):360-367. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.360

View: 7398 Download: 31 Crossref: 13

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C

Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim

Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.272

View: 7264 Download: 38 Crossref: 1

Editorial

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Woo Jin Chung

Clin Mol Hepatol. 2012;18(3):268-271. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.268

View: 5607 Download: 45 Crossref: 1

Original Article

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin

Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol

Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.183

View: 6880 Download: 34 Crossref: 3

Case Report

Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C

Jae Hee Lim, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee, Tae Kwann Park

Clin Mol Hepatol. 2011;17(1):61-65. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.61

View: 8343 Download: 48 Crossref: 11

Review

New treatments for chronic hepatitis C

Jae Young Jang, Raymond T. Chung

Clin Mol Hepatol. 2010;16(3):263-277. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.263

View: 8071 Download: 44 Crossref: 14

3

Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection

Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D., Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.

Clin Mol Hepatol. 2010;16(1):38-48. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.38

View: 5212 Download: 20 Crossref: 9

Current status of Liver diseases in Korea: Hepatitis C

Young Suk Lim

Clin Mol Hepatol. 2009;15(60):25-28. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S25

View: 5994 Download: 27 Crossref: 20

A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C

Mi Na Kim, M.D. Ki Tae Yoon, M.D. Jun Yong Park, M.D. Do Young Kim, M.D. Sang Hoon Ahn, M.D. Chae Yoon Chon, M.D. Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2009;15(4):496-503. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.496

View: 4673 Download: 18 Crossref: 2

4

A case of sudden-onset hearing Loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis C

Min Ki Shin , Tae Hyo Kim , Kang Ju , Chang Yoon Ha , Hyun Ju Min , Woon Tae Jung , Ok Jae Lee

Clin Mol Hepatol. 2009;15(3):370-374. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.370

View: 4503 Download: 25 Crossref: 3

A Case of Bell`s Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

Moo Yeol Lee, M.D., Hoon Cho, M.D., Yeong Muk Kim, M.D., and Joon Sang Lee, M.D.

Clin Mol Hepatol. 2006;12(3):444-448. Published online January 1, 2000

View: 2606 Download: 17

3

Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C

Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee

Clin Mol Hepatol. 1998;4(2):109-119.

View: 2380 Download: 14

1 |

Viewed By 5323	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5269	MAFLD: How is it different from NAFLD?
Viewed By 5159	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3873	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3816	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search